恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
恒瑞医药(600276) 利润表
单位:万元
报表日期2022-09-302022-06-302022-03-312021-12-312021-09-30
一、营业总收入1,594,530.541,022,804.18547,853.912,590,552.642,019,896.85
营业收入1,594,530.541,022,804.18547,853.912,590,552.642,019,896.85
二、营业总成本1,256,917.74798,799.48415,719.012,179,296.851,531,885.33
营业成本266,874.81168,792.6085,529.49374,179.86272,856.73
营业税金及附加14,392.159,313.775,060.9420,180.5415,689.29
销售费用516,169.59326,667.69175,847.31938,370.83699,580.34
管理费用146,830.5297,670.7355,928.95286,030.66153,858.15
财务费用-37,103.18-22,070.34-7,375.78-33,795.64-24,294.88
研发费用349,753.86218,425.03100,728.10594,330.60414,195.69
资产减值损失----------
公允价值变动收益-161.711,610.95-1,027.093,623.26-4,565.84
投资收益10,740.935,597.742,947.4921,343.3916,807.58
其中:对联营企业和合营企业的投资收益-------694.01--
汇兑收益----------
三、营业利润365,183.23239,862.62136,572.43466,481.61507,304.65
加:营业外收入140.3394.8636.45222.29306.45
减:营业外支出11,924.294,771.2967.5720,073.0314,727.85
其中:非流动资产处置损失----------
四、利润总额353,399.27235,186.19136,541.31446,630.88492,883.25
减:所得税费用43,794.6128,380.2415,714.22-1,771.8173,693.17
五、净利润309,604.66206,805.95120,827.09448,402.69419,190.08
归属于母公司所有者的净利润317,338.99211,933.17123,694.92453,021.76420,720.10
少数股东损益-7,734.33-5,127.22-2,867.82-4,619.07-1,530.02
六、每股收益
基本每股收益(元/股)0.50000.33000.19000.71000.6600
稀释每股收益(元/股)0.50000.33000.19000.71000.6600
七、其他综合收益-663.05-402.22-13.35-784.01-85.78
八、综合收益总额308,941.61206,403.73120,813.75447,618.68419,104.30
归属于母公司所有者的综合收益总额316,593.12211,471.39123,692.39452,285.14420,648.96
归属于少数股东的综合收益总额-7,651.51-5,067.67-2,878.65-4,666.46-1,544.66
下载全部历史数据到excel中 返回页顶